Umbilical Cord Blood Mononuclear Cell Gel in the Treatment of Refractory Diabetic Foot Ulcer
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Umbilical cord blood mononuclear cells (MNC) may improve the wound repair ability. This study
aims to investigate the role of MNC in refractory diabetic foot ulcer by comparing the
combination of PRP and MNC with PRP alone.